|
|
cardiac right ventricle morphogenesis
|
GO:0003215 |
3 |
0.637
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.383
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.373
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.307
|
|
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.254
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.233
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.220
|
|
|
|
positive regulation of monocyte chemotactic protein 1 production
|
GO:0071639 |
3 |
0.217
|
|
|
|
basophil differentiation
|
GO:0030221 |
2 |
0.186
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.158
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.154
|
Human |
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.137
|
|
|
|
neuroendocrine cell differentiation
|
GO:0061101 |
2 |
0.135
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.130
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.128
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
1 |
0.122
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014067 |
4 |
0.114
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
2 |
0.113
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.113
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.108
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.107
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.100
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.099
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.096
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
4 |
0.096
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.096
|
Human |
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.093
|
|
|
|
spinal cord development
|
GO:0021510 |
4 |
0.092
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.091
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.089
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.089
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.088
|
Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.086
|
|
|
|
blood vessel maturation
|
GO:0001955 |
1 |
0.085
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.085
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.085
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.084
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.083
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.083
|
|
|
|
positive regulation of chromatin assembly or disassembly
|
GO:0045799 |
2 |
0.082
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.078
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.073
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.072
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.071
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.070
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.070
|
Human |
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.069
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.067
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.067
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.067
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.067
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.067
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.067
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.066
|
|
|
|
eosinophil differentiation
|
GO:0030222 |
2 |
0.066
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.066
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.066
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.065
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.065
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.065
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.065
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.065
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.064
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.062
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.061
|
Human |
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.060
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
3 |
0.060
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.060
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.060
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.059
|
|
|
|
erythrocyte maturation
|
GO:0043249 |
1 |
0.059
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.059
|
|
|
|
platelet formation
|
GO:0030220 |
4 |
0.058
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.058
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.058
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.057
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
3 |
0.057
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.057
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.055
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.055
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.053
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.052
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.052
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.052
|
Human |
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.052
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.051
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.051
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.051
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.050
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.050
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.048
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
2 |
0.048
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.048
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.048
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.048
|
|
|
|
regulation of axon extension involved in axon guidance
|
GO:0048841 |
2 |
0.047
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.047
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.046
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.046
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.046
|
|
|
|
regulation of endothelial cell differentiation
|
GO:0045601 |
4 |
0.045
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.045
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.044
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.044
|
Human |
|
|
oogenesis
|
GO:0048477 |
2 |
0.044
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.044
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.044
|
|
|
|
forebrain neuron development
|
GO:0021884 |
2 |
0.044
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.044
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.043
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.043
|
Human |
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.043
|
|
|
|
outflow tract septum morphogenesis
|
GO:0003148 |
4 |
0.043
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.043
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.043
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.043
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.042
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.042
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.042
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.042
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.041
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.041
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.041
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.041
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.041
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.041
|
|
|
|
eyelid development in camera type eye
|
GO:0061029 |
2 |
0.040
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.040
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
4 |
0.040
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.040
|
Human |
|
|
erythrocyte development
|
GO:0048821 |
3 |
0.039
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.039
|
|
|
|
blastocyst formation
|
GO:0001825 |
3 |
0.039
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.039
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.039
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.038
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.038
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.038
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.038
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.038
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
23 |
0.038
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.037
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.037
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.037
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.037
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.037
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.037
|
Human |
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.037
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.036
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.036
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.036
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.036
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.036
|
|
|
|
positive regulation of interleukin 5 production
|
GO:0032754 |
3 |
0.035
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.035
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.035
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.034
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.034
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.034
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.034
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.034
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.034
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.033
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.033
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.033
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
4 |
0.033
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.032
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.032
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.032
|
Human |
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.031
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.031
|
|
|
|
platelet morphogenesis
|
GO:0036344 |
4 |
0.031
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.031
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.031
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.031
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.031
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.031
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.031
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
57 |
0.030
|
Human |
|
|
response to other organism
|
GO:0051707 |
261 |
0.030
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.030
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.030
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.030
|
Human |
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.030
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.030
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.030
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.029
|
|
|
|
system process
|
GO:0003008 |
349 |
0.029
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.029
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.029
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.028
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.028
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.028
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.028
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.028
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.028
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.028
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.027
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.027
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.027
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.027
|
Human |
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.027
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.027
|
Human |
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.027
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.027
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.027
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.027
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.027
|
Human |
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.026
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.026
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.026
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.026
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.026
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.025
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.025
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.025
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.025
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.025
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
4 |
0.025
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.025
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.025
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
4 |
0.025
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.025
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.024
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.024
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.024
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
70 |
0.024
|
Human |
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.024
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.024
|
|
|
|
head development
|
GO:0060322 |
108 |
0.024
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.024
|
|
|
|
negative regulation of axon guidance
|
GO:1902668 |
1 |
0.023
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.023
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.023
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.023
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.023
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.023
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.023
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.023
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.023
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.023
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.023
|
|
|
|
memory
|
GO:0007613 |
3 |
0.023
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
1 |
0.023
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.023
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.023
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.022
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.022
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.022
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.022
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.022
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.022
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.022
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.022
|
|
|
|
positive regulation of interleukin 13 production
|
GO:0032736 |
4 |
0.022
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.022
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.022
|
Human |
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.022
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.022
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.022
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.022
|
|
|
|
mating
|
GO:0007618 |
1 |
0.022
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.022
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.022
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.022
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.021
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.021
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.021
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.021
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.021
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.021
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
85 |
0.021
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
1 |
0.021
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.021
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.021
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.021
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.021
|
|
|
|
gabaergic neuron differentiation
|
GO:0097154 |
1 |
0.021
|
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
2 |
0.021
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.021
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.020
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.020
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.020
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.020
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.020
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.020
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.020
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.020
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.020
|
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.020
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.020
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.020
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.020
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.020
|
|
|
|
negative regulation of macrophage differentiation
|
GO:0045650 |
2 |
0.020
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.020
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.020
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.020
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.020
|
|
|
|
positive regulation of endothelial cell differentiation
|
GO:0045603 |
2 |
0.020
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.020
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.020
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.020
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.019
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.019
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.019
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.019
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.019
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.019
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.019
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.019
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.019
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.019
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.019
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.019
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.019
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
2 |
0.019
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.019
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.019
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.019
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.019
|
|
|
|
negative regulation of neural precursor cell proliferation
|
GO:2000178 |
1 |
0.019
|
|
|
|
circadian behavior
|
GO:0048512 |
2 |
0.019
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.019
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.018
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.018
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.018
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.018
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.018
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.018
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.018
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.018
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.018
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.018
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.018
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.018
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.018
|
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.018
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.018
|
|
|
|
interleukin 6 production
|
GO:0032635 |
37 |
0.018
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.018
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.018
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.018
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.018
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
172 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.018
|
|
|
|
lateral mesoderm development
|
GO:0048368 |
1 |
0.017
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.017
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.017
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.017
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.017
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.017
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.017
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.017
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.017
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
83 |
0.017
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
37 |
0.017
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.017
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.017
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.017
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.017
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.017
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.017
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.017
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.017
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.017
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
29 |
0.017
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.017
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.017
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.017
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.017
|
Human |
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.017
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
45 |
0.017
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.017
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.017
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.016
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.016
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.016
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.016
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.016
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
56 |
0.016
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.016
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.016
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.016
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.016
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.016
|
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.016
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.016
|
|
|
|
endocardial cushion development
|
GO:0003197 |
3 |
0.016
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.016
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
92 |
0.016
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.016
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.016
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.015
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.015
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.015
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.015
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.015
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.015
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.015
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.015
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.015
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.015
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.015
|
|
|
|
negative regulation of response to external stimulus
|
GO:0032102 |
83 |
0.015
|
|
|
|
negative regulation of catabolic process
|
GO:0009895 |
104 |
0.015
|
|
|
|
hemostasis
|
GO:0007599 |
76 |
0.015
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.015
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.015
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.015
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.015
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.015
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.015
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.015
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.015
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.015
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.015
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.015
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.015
|
|
|
|
bone mineralization
|
GO:0030282 |
34 |
0.015
|
|
|
|
lipid oxidation
|
GO:0034440 |
33 |
0.015
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.015
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.015
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.015
|
|
|
|
behavioral response to ethanol
|
GO:0048149 |
2 |
0.015
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.015
|
|
|
|
v d j recombination
|
GO:0033151 |
3 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.015
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.015
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.015
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.015
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
50 |
0.015
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.015
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.015
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.015
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.015
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.015
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.015
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.014
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.014
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.014
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.014
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
50 |
0.014
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.014
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.014
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
1 |
0.014
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.014
|
Human |
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.014
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.014
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.014
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.014
|
|
|
|
regulation of double strand break repair
|
GO:2000779 |
22 |
0.014
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
82 |
0.014
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.014
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.014
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.014
|
|
|
|
regulation of stem cell maintenance
|
GO:2000036 |
4 |
0.014
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.014
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
101 |
0.014
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.014
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.014
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.014
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.014
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.014
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.014
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.014
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.014
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.014
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.014
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.014
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
25 |
0.014
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
60 |
0.014
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.014
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.014
|
|
|
|
positive regulation of neurogenesis
|
GO:0050769 |
49 |
0.014
|
Human |
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.014
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.014
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.014
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.014
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.014
|
|
